Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Primary immunodeficiency diseases : definition, diagnosis, and management / Nima Rezaei, Asghar Aghamohammadi, Luigi D. Notarangelo, editors.

Contributor(s): Aghamohammadi, Asghar,, editor literario | Notarangelo, Luigi,, editor literario | Rezaei, Nima,, editor literario
Material type: materialTypeLabelE-bookPublisher: Berlin, Germany : Springer, [2016]Copyright date: 2017Edition: Second edition.Description: 1 recurso en línea.ISBN: 3662529092; 9783662529096.Subject: Enfermedades inmunológicasOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Foreword; Preface; Contents; Contributors; 1: Introduction on Primary Immunodeficiency Diseases; 1.1 Definition; 1.1.1 Background; 1.1.2 History; 1.1.3 Epidemiology; 1.2 Etiology; 1.2.1 Classification; 1.2.2 Genetic Defects; 1.2.3 Pathophysiology; 1.3 Clinical Manifestations; 1.3.1 Infections; 1.3.2 Autoimmunity and Inflammatory Conditions; 1.3.3 Malignancies; 1.3.4 Other Manifestations; 1.4 Diagnosis; 1.4.1 Warning Signs and Symptoms; 1.4.2 Diagnostic Approach; 1.4.3 Approach to Laboratory Tests; 1.4.4 Phenotypic Approach; 1.5 Management; 1.5.1 General Considerations
1.5.2 Vaccination1.5.3 Antibiotics; 1.5.4 Immunoglobulin Replacement Therapy; 1.5.5 Transplantation; 1.5.6 Gene Therapy; 1.5.7 Adjunct Therapies; 1.5.8 Prevention; 1.5.9 Newborn Screening; References; 2: Combined T- and B-Cell Immunodeficiencies; 2.1 Introduction; 2.2 T-B+ Severe Combined Immunodeficiency; 2.2.1 Definition; 2.2.2 Etiology; 2.2.3 Clinical Manifestations; 2.2.4 Diagnosis; 2.2.5 Management; 2.3 T-B- Severe Combined Immunodeficiency; 2.3.1 Definition; 2.3.2 Etiology; 2.3.3 Clinical Manifestations; 2.3.4 Diagnosis; 2.3.5 Management; 2.4 Omenn Syndrome
2.12 Combined Immunodeficiencies with Immuno-Osseous Dysplasias2.12.1 Definition; 2.12.2 Etiology; 2.12.3 Clinical Manifestations; 2.12.4 Diagnosis; 2.12.5 Management; 2.13 Combined Immunodeficiency with Intestinal Atresias (TTC7A Deficiency); 2.13.1 Definition; 2.13.2 Etiology; 2.13.3 Clinical Manifestations; 2.13.4 Diagnosis; 2.13.5 Management; 2.14 MHC Class II Deficiency; 2.14.1 Definition; 2.14.2 Etiology; 2.14.3 Clinical Manifestations; 2.14.4 Diagnosis; 2.14.5 Management; 2.15 MHC Class I Deficiency; 2.15.1 Definition; 2.15.2 Etiology
2.4.1 Definition2.4.2 Etiology; 2.4.3 Clinical Manifestations; 2.4.4 Diagnosis; 2.4.5 Management; 2.5 Purine Salvage Pathway Defects; 2.5.1 Definition; 2.5.2 Etiology; 2.5.3 Clinical Manifestations; 2.5.4 Diagnosis; 2.5.5 Management; 2.6 AK2 Deficiency; 2.6.1 Definition; 2.6.2 Etiology; 2.6.3 Clinical Manifestations; 2.6.4 Diagnosis; 2.6.5 Management; 2.7 DOCK2 Deficiency; 2.7.1 Definition; 2.7.2 Etiology; 2.7.3 Clinical Manifestations; 2.7.4 Diagnosis; 2.7.5 Management; 2.8 Immunoglobulin Class Switch Recombination Deficiencies Affecting CD40-CD40L; 2.8.1 Definition
2.8.2 Etiology2.8.3 Clinical Manifestations; 2.8.4 Diagnosis; 2.8.5 Management; 2.9 Complete DiGeorge Syndrome; 2.9.1 Definition; 2.9.2 Etiology; 2.9.3 Clinical Manifestations; 2.9.4 Diagnosis; 2.9.5 Management; 2.10 CHARGE Syndrome; 2.10.1 Definition; 2.10.2 Etiology; 2.10.3 Clinical Manifestations; 2.10.4 Diagnosis; 2.10.5 Management; 2.11 Combined Immunodeficiency with Alopecia Totalis (WHN Deficiency); 2.11.1 Definition; 2.11.2 Etiology; 2.11.3 Clinical Manifestations; 2.11.4 Diagnosis; 2.11.5 Management
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC606 .P756 2016 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20022605
Total holds: 0

Incluye índice

SpringerLink

Foreword; Preface; Contents; Contributors; 1: Introduction on Primary Immunodeficiency Diseases; 1.1 Definition; 1.1.1 Background; 1.1.2 History; 1.1.3 Epidemiology; 1.2 Etiology; 1.2.1 Classification; 1.2.2 Genetic Defects; 1.2.3 Pathophysiology; 1.3 Clinical Manifestations; 1.3.1 Infections; 1.3.2 Autoimmunity and Inflammatory Conditions; 1.3.3 Malignancies; 1.3.4 Other Manifestations; 1.4 Diagnosis; 1.4.1 Warning Signs and Symptoms; 1.4.2 Diagnostic Approach; 1.4.3 Approach to Laboratory Tests; 1.4.4 Phenotypic Approach; 1.5 Management; 1.5.1 General Considerations

1.5.2 Vaccination1.5.3 Antibiotics; 1.5.4 Immunoglobulin Replacement Therapy; 1.5.5 Transplantation; 1.5.6 Gene Therapy; 1.5.7 Adjunct Therapies; 1.5.8 Prevention; 1.5.9 Newborn Screening; References; 2: Combined T- and B-Cell Immunodeficiencies; 2.1 Introduction; 2.2 T-B+ Severe Combined Immunodeficiency; 2.2.1 Definition; 2.2.2 Etiology; 2.2.3 Clinical Manifestations; 2.2.4 Diagnosis; 2.2.5 Management; 2.3 T-B- Severe Combined Immunodeficiency; 2.3.1 Definition; 2.3.2 Etiology; 2.3.3 Clinical Manifestations; 2.3.4 Diagnosis; 2.3.5 Management; 2.4 Omenn Syndrome

2.12 Combined Immunodeficiencies with Immuno-Osseous Dysplasias2.12.1 Definition; 2.12.2 Etiology; 2.12.3 Clinical Manifestations; 2.12.4 Diagnosis; 2.12.5 Management; 2.13 Combined Immunodeficiency with Intestinal Atresias (TTC7A Deficiency); 2.13.1 Definition; 2.13.2 Etiology; 2.13.3 Clinical Manifestations; 2.13.4 Diagnosis; 2.13.5 Management; 2.14 MHC Class II Deficiency; 2.14.1 Definition; 2.14.2 Etiology; 2.14.3 Clinical Manifestations; 2.14.4 Diagnosis; 2.14.5 Management; 2.15 MHC Class I Deficiency; 2.15.1 Definition; 2.15.2 Etiology

2.4.1 Definition2.4.2 Etiology; 2.4.3 Clinical Manifestations; 2.4.4 Diagnosis; 2.4.5 Management; 2.5 Purine Salvage Pathway Defects; 2.5.1 Definition; 2.5.2 Etiology; 2.5.3 Clinical Manifestations; 2.5.4 Diagnosis; 2.5.5 Management; 2.6 AK2 Deficiency; 2.6.1 Definition; 2.6.2 Etiology; 2.6.3 Clinical Manifestations; 2.6.4 Diagnosis; 2.6.5 Management; 2.7 DOCK2 Deficiency; 2.7.1 Definition; 2.7.2 Etiology; 2.7.3 Clinical Manifestations; 2.7.4 Diagnosis; 2.7.5 Management; 2.8 Immunoglobulin Class Switch Recombination Deficiencies Affecting CD40-CD40L; 2.8.1 Definition

2.8.2 Etiology2.8.3 Clinical Manifestations; 2.8.4 Diagnosis; 2.8.5 Management; 2.9 Complete DiGeorge Syndrome; 2.9.1 Definition; 2.9.2 Etiology; 2.9.3 Clinical Manifestations; 2.9.4 Diagnosis; 2.9.5 Management; 2.10 CHARGE Syndrome; 2.10.1 Definition; 2.10.2 Etiology; 2.10.3 Clinical Manifestations; 2.10.4 Diagnosis; 2.10.5 Management; 2.11 Combined Immunodeficiency with Alopecia Totalis (WHN Deficiency); 2.11.1 Definition; 2.11.2 Etiology; 2.11.3 Clinical Manifestations; 2.11.4 Diagnosis; 2.11.5 Management

Online resource; title from PDF title page (SpringerLink, viewed December 8, 2016).

There are no comments on this title.

to post a comment.
Share